Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
While certain medications should not be used together at all, in other cases, two different drugs may need to be administered in combination even if interactions are likely to occu···【more】
Article source：Captain MedicineRelease date：2026-01-16Recommended：29
Please keep all scheduled appointments with your doctor and the laboratory on time. Your doctor will conduct laboratory tests before treatment to determine whether your cancer is e···【more】
Article source：Captain MedicineRelease date：2026-01-16Recommended：24
Pralsetinib may interfere with the efficacy of hormonal contraceptives (including birth control pills, patches, vaginal rings, implants, or injections). These should not be used as···【more】
Article source：Captain MedicineRelease date：2026-01-16Recommended：27
Although severe adverse reactions to Pralsetinib (brand name: Gavreto) are relatively rare, the drug may still induce certain severe side effects, requiring close monitoring during···【more】
Article source：Captain MedicineRelease date：2026-01-16Recommended：22
Pralsetinib is indicated for the treatment of adult patients with specific types of non-small cell lung cancer (NSCLC) that has metastasized to other parts of the body.What side ef···【more】
Article source：Captain MedicineRelease date：2026-01-16Recommended：24
The efficacy of Pralsetinib was investigated in a multicenter, open-label, multi-cohort clinical trial (ARROW, NCT03037385).Is Pralsetinib Effective in Treatment?A total of 220 pat···【more】
Article source：Captain MedicineRelease date：2026-01-16Recommended：27
Pralsetinib is the sixth drug under Genentech that has obtained FDA approval for the treatment of lung cancer.How Effective is Pralsetinib?The FDA has granted this drug Breakthroug···【more】
Article source：Captain MedicineRelease date：2026-01-16Recommended：28
Please take pralsetinib strictly in accordance with the instructions of medical professionals.How to Take PralsetinibTake the medication once daily, with the dosage following the d···【more】
Article source：Captain MedicineRelease date：2026-01-16Recommended：28
Pralsetinib, also known as GAVRETO, is a targeted therapy medication administered orally once daily. It is indicated for the treatment of certain cancers caused by abnormal RET gen···【more】
Article source：Captain MedicineRelease date：2026-01-16Recommended：29
Pralsetinib is a tyrosine kinase inhibitor administered via oral route.Which Patients Are Suitable for Pralsetinib?Pralsetinib (trade name: Gavreto) is a pharmaceutical agent appro···【more】
Article source：Captain MedicineRelease date：2026-01-16Recommended：20
Trabectedin (Yondelis) is a prescription medication indicated for the treatment of specific types of soft tissue sarcomas (e.g., liposarcoma and leiomyosarcoma) in patients who hav···【more】
Article source：Captain MedicineRelease date：2026-01-16Recommended：31
On December 1, 2020, South San Francisco, California – Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has approved Gavreto™ (pra···【more】
Article source：Captain MedicineRelease date：2026-01-15Recommended：25
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：672025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：3672024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：602025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：792025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：742025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：942025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：902025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：932025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
